Trials / Completed
CompletedNCT04485520
Efficacy of the Extract of Carica Papaya as an Inhibitor of Streptococcus Mutans
Efficacy of the Extract of Carica Papaya as an Inhibitor of Streptococcus Mutans in Students of the Faculty of Dentistry in the Year 2018
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Julieta María Méndez Romero · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Papaya has effects on oral pathogenic microorganisms, it also has anticoagulant quality, amebicidal action, antimicrobial, bacteriostatic and antifungal activity on different bacteria, especially on Streptococcus mutans, this can be exploited in the dental area. The objective of the study was to determine the efficacy of Carica Papaya peel extract (suckling) as an inhibitor of Streptococcus Mutans in students of the dental faculty of the National University of Caaguazú in 2018.
Detailed description
Specific objectives * To determine the inhibition of the extract of the peel of Carica Papaya (baby) at 3% on Streptococcus Mutans by age and sex grouping. * To quantify the inhibition of the extract of the peel of Carica Papaya (baby) at 3% on the growth of Streptococcus Mutans before, at 10 minutes and 8 days of use in the experimental group. * Quantify the inhibition of 0.12% Chlorhexidine Gluconate on the growth of Streptococcus Mutans before, after 10 minutes and 8 days of use in the control group. * Compare the count of Colony Forming Units (CFU) between both groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | CARICA PAPAYA MOUTHWASH | Each application was 10 ml. applied for 1 minute, once a day for 8 days |
| OTHER | CHLORHEXIDINE MOUTHWASH | Each application was 10 ml. applied for 1 minute, once a day for 8 days |
Timeline
- Start date
- 2017-09-21
- Primary completion
- 2017-10-21
- Completion
- 2017-10-21
- First posted
- 2020-07-24
- Last updated
- 2021-08-18
Locations
1 site across 1 country: Paraguay
Source: ClinicalTrials.gov record NCT04485520. Inclusion in this directory is not an endorsement.